openPR Logo
Press release

Investigation announced for Long-Term Investors in shares of Livongo Health, Inc. (NASDAQ: LVGO)

01-13-2020 04:24 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

An investigation on behalf of investors in Livongo Health, Inc. (NASDAQ: LVGO) shares over potential wrongdoing at Livongo Health,

An investigation on behalf of investors in Livongo Health, Inc. (NASDAQ: LVGO) shares over potential wrongdoing at Livongo Health,

An investigation on behalf of current long-term investors in shares of Livongo Health, Inc. (NASDAQ: LVGO) was announced over potential breaches of fiduciary duties by certain officers and directors at Livongo Health, Inc. .

Investors who purchased shares of Livongo Health, Inc. (NASDAQ: LVGO) and currently hold any of those NASDAQ: LVGO shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm concerns whether certain Livongo Health, Inc. (NASDAQ: LVGO officers and directors breached their fiduciary duties and caused damage to the company and its shareholders.

Mountain View, CA based Livongo Health, Inc. provides an integrated suite of solutions for the healthcare industry in North America. On July 24, 2019, Livongo Health, Inc announced the pricing of its initial public offering (“IPO”) of approximately 12.7 million shares at $28.00 per share. Livongo Health, Inc raised $355.60 million in its IPO.

Since, the IPO shares of Livongo Health, Inc. (NASDAQ: LVGO) declined to as low as $15.12 per share on October 2, 2019.

Those who purchased shares of Livongo Health, Inc. (NASDAQ: LVGO) have certain options and should contact the Shareholders Foundation.

Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation announced for Long-Term Investors in shares of Livongo Health, Inc. (NASDAQ: LVGO) here

News-ID: 1895012 • Views: 170

More Releases from Shareholders Foundation

Lawsuit filed for Investors in shares of Green Dot Corporation (NYSE: GDOT)
An investor, who purchased shares of Green Dot Corporation (NYSE: GDOT), filed a lawsuit over alleged Securities Laws violations by Green Dot Corporation in connection with certain allegedly false and misleading statements. Investors who purchased shares of Green Dot Corporation (NYSE: GDOT) have certain options and for certain investors are short and strict deadlines running. Deadline: February 17, 2020. NYSE: GDOT investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or
Investigation for Long-Term Investors in shares of Nektar Therapeutics (NASDAQ: …
An investigation was annpounced concerning potential breaches of fiduciary duties by certain directors and officers of Nektar Therapeutics. Investors who are current long term investors in Nektar Therapeutics (NASDAQ: NKTR) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in NASDAQ: NKTR stocks follows a lawsuit filed against Nektar Therapeutics over
Deadline coming up on Jan. 20th in Lawsuit filed for Investors in shares of Cano …
A deadline is coming up on January 20, 2020 in the lawsuit filed for certain investors of Canopy Growth Corporation (NYSE: CGC) over alleged securities laws violations by Canopy Growth Corporation. Investors who purchased shares of Canopy Growth Corporation (NYSE: CGC) have certain options and there are strict and short deadlines running. Deadline: January 20, 2020. NYSE: CGC stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 -
Investigation for Investors in NYSE: LTHM shares announced over potential Securi …
Livent Corporation is under investigation concerning potential securities laws in connection with certain financial statements. Investors who purchased shares of Livent Corporation (NYSE: LTHM), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Livent Corporation (NYSE: LTHM) concerning whether a series of statements by Livent Corporation

All 5 Releases


More Releases for Livongo

Digital Therapeutics Market Expected to reach At + US$ 8,941.1 Mn by 2025 With M …
Global digital therapeutics market is expected to reach US$ 8,941.1 Mn by 2025 from US$ 1,993.2 Mn in 2017. The market is estimated to grow with a CAGR of 20.8% during the forecast period from 2018 to 2025. North America is the largest geographic market and it is expected to be the largest revenue generator during the forecast period, whereas the market is expected to witness growth at a significant
Latest Technology on Digital Therapeutics Industry Trend by Top Vendors: Omada H …
The worldwide market for Digital Therapeutics is expected to grow at a CAGR of roughly 30.3% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new study. Get Sample copy @ https://www.orianresearch.com/request-sample/648879 Digital therapeutics refers to health or social care interventions delivered through a smart device to support healthy behaviors and provide therapeutic effects. Digital therapies/programs are cost-effective and have
Global Digital Therapeutics Market 2019 - Welldoc, Inc., Livongo Health, Noom In …
Digital therapeutics refers to health or social care interventions delivered through a smart device to support healthy behaviors and provide therapeutic effects. Digital therapies/programs are cost-effective and have the potential to improve patient engagement and bring a substantial change in patients’ health. Owing to these advantages, digital therapeutics is increasingly being prescribed to help manage long-term conditions such as diabetes, insomnia, and asthma. Scope of the Report: This report focuses on the
Digital Therapeutics & Wellness Global Market 2018: Key Players – Canary Healt …
Digital Therapeutics & Wellness Industry Description Wiseguyreports.Com Adds “Digital Therapeutics & Wellness -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2023” To Its Research Database Digital Therapeutics is an innovative new class of medicine that gives participants access to the world's most effective behavior therapies, enhanced with smart technology, and delivered directly to their fingerprints or front door. Digital therapeutics may be up and coming, but they also have
Digital Medicine Market By Key Players: 2Morrow, Ginger, Akili, Livongo, AliveCo …
Digital Medicine Industry Overview Digital medicine technology is an innovative technological technique that has bridged the unsought gap between healthcare and digital technology. The Digital Medicine market research study relies upon a combination of primary as well as secondary research. It throws light on the key factors concerned with generating and limiting Digital Medicine market growth. In addition, the current mergers and acquisition by key players in the market have been described at length. Additionally, the historical information and current growth of the market have been given in the scope of
Digital Medicine Market by Technology & Application – 2Morrow, Ginger, Akili, …
Qyresearchreports include new market research report “Global Digital Medicine Market Size, Status and Forecast 2025” to its huge collection of research reports. Digital medicine technology is an innovative technological technique that has bridged the unsought gap between healthcare and digital technology. Due to evolution in health care, scientific medicine introduced the concept of digital medicine which aims in providing individualized medicine by knowing the biology of a patient through a wireless sensor